Showing posts with label Oncothyreon. Show all posts
Showing posts with label Oncothyreon. Show all posts

Wednesday, May 11, 2011

Price Targets on (LMNX) (LOPE) (ONTY) (PAA) (PODD) Updated

Price targets on Luminex (NASDAQ: LMNX), Grand Canyon Education Incorporated (NASDAQ: LOPE), Oncothyreon Inc . (NASDAQ: ONTY), Plains All American (NYSE: PAA) and Insulet Corp. (NASDAQ: PODD) updated by analysts.

Jefferies (NYSE:JEF cut their price target on Luminex (LMNX) from $17.00 to $16.00. They have a “hold” rating on the company.

Bank of America (NYSE:BAC) cut their price target on Grand Canyon Education Incorporated (LOPE) from $18.00 to $17.00. They have a “neutral” rating on the company.

Wedbush raised their price target on Oncothyreon Inc . (ONTY) from $6.00 to $7.00.

Citigroup (NYSE:C) raised their price target on Plains All Amer (PAA) from $70.00 to $71.00. They have a “buy” rating on the company.

Jefferies (NYSE:JEF) raised their price target on Insulet Corp. (PODD) from $20.00 to $24.00. They have a “buy” rating on the company.